BrainCool

THE BRAINCOOL™ SYSTEM FOR STROKE AND CARDIAC ARREST

BrainCool AB is a Swedish medical device company listed since May 2014 on the Swedish Stock Exchange.

The vision is to create “The Medical Cooling Company” with a clear focus on bringing products with highly innovative, medical cooling technologies with an initial focus on brain cooling for stroke and cardiac arrest and the prevention of oral mucositis. These products will create a de facto standard in their field.

Therapeutic hypothermia, or cooling, lowers a patient’s body temperature to help reduce the risk of injury to the brain following a period of insufficient blood flow due to an ischemic event, such as cardiac arrest, stroke or traumatic brain injury. Cooling begins after the patient is admitted to the hospital.

Two landmark human studies published simultaneously in 2002 by the New England Journal of Medicine demonstrated the positive effects of mild hypothermia applied following cardiac arrest.

BRAIN COOLING

•A brain hypothermia device for the stroke market – The BrainCoolSystem

•A brain hypothermia device for the cardiac arrest market – The BrainCoolSystem ( the same product with a different configuration )

The system includes a state of the art cooling unit with advanced monitoring and shiver control settings along with the single patient use accessories – BrainCool Pads

THE BRAINCOOL™ SYSTEM FOR STROKE AND CARDIAC ARREST

For more information please contact us on 1300 309 994 or info@aurorabioscience.com.au

Additional information, including information on new technologies for concussion and oral mucositis (both not currently TGA approved)  can be obtained from the manufacturers website by clicking on the logo below: